The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Plasma Fraction-Global Market Insights and Sales Trends 2024
Synopsis
Blood plasma fractionation refers to the general processes of separating the various components of blood plasma, which in turn is a component of blood obtained through blood fractionation.
The global Plasma Fraction market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Plasma Fraction in various end use industries. The expanding demands from the Hospitals, Clinics and Ambulatory Surgical Centers,, are propelling Plasma Fraction market. Protease Inhibitors, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Protease segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Plasma Fraction, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Plasma Fraction market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Plasma Fraction market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Plasma Fraction sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Plasma Fraction covered in this report include Baxter, Octapharma, Biotest, CSL, Grifols, Kedrion, LFB, Chinese Biological Products and Shanghai RAAS Blood Products, etc.
The global Plasma Fraction market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Baxter
Octapharma
Biotest
CSL
Grifols
Kedrion
LFB
Chinese Biological Products
Shanghai RAAS Blood Products
Global Plasma Fraction market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Plasma Fraction market, Segment by Type:
Protease Inhibitors
Protease
Fibrinolytic Proteins
Coagulation Factors
Anti-Coagulant Proteins
Global Plasma Fraction market, by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Plasma Fraction companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Blood plasma fractionation refers to the general processes of separating the various components of blood plasma, which in turn is a component of blood obtained through blood fractionation.
The global Plasma Fraction market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Plasma Fraction in various end use industries. The expanding demands from the Hospitals, Clinics and Ambulatory Surgical Centers,, are propelling Plasma Fraction market. Protease Inhibitors, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Protease segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Plasma Fraction, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Plasma Fraction market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Plasma Fraction market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Plasma Fraction sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Plasma Fraction covered in this report include Baxter, Octapharma, Biotest, CSL, Grifols, Kedrion, LFB, Chinese Biological Products and Shanghai RAAS Blood Products, etc.
The global Plasma Fraction market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Baxter
Octapharma
Biotest
CSL
Grifols
Kedrion
LFB
Chinese Biological Products
Shanghai RAAS Blood Products
Global Plasma Fraction market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Plasma Fraction market, Segment by Type:
Protease Inhibitors
Protease
Fibrinolytic Proteins
Coagulation Factors
Anti-Coagulant Proteins
Global Plasma Fraction market, by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Plasma Fraction companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Plasma Fraction
1.1 Plasma Fraction Market Overview
1.1.1 Plasma Fraction Product Scope
1.1.2 Plasma Fraction Market Status and Outlook
1.2 Global Plasma Fraction Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Plasma Fraction Market Size by Region (2018-2029)
1.4 Global Plasma Fraction Historic Market Size by Region (2018-2023)
1.5 Global Plasma Fraction Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Plasma Fraction Market Size (2018-2029)
1.6.1 North America Plasma Fraction Market Size (2018-2029)
1.6.2 Europe Plasma Fraction Market Size (2018-2029)
1.6.3 Asia-Pacific Plasma Fraction Market Size (2018-2029)
1.6.4 Latin America Plasma Fraction Market Size (2018-2029)
1.6.5 Middle East & Africa Plasma Fraction Market Size (2018-2029)
2 Plasma Fraction Market by Type
2.1 Introduction
2.1.1 Protease Inhibitors
2.1.2 Protease
2.1.3 Fibrinolytic Proteins
2.1.4 Coagulation Factors
2.1.5 Anti-Coagulant Proteins
2.2 Global Plasma Fraction Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Plasma Fraction Historic Market Size by Type (2018-2023)
2.2.2 Global Plasma Fraction Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Plasma Fraction Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Plasma Fraction Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Plasma Fraction Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Plasma Fraction Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Plasma Fraction Revenue Breakdown by Type (2018-2029)
3 Plasma Fraction Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Ambulatory Surgical Centers
3.2 Global Plasma Fraction Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Plasma Fraction Historic Market Size by Application (2018-2023)
3.2.2 Global Plasma Fraction Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Plasma Fraction Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Plasma Fraction Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Plasma Fraction Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Plasma Fraction Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Plasma Fraction Revenue Breakdown by Application (2018-2029)
4 Plasma Fraction Competition Analysis by Players
4.1 Global Plasma Fraction Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Plasma Fraction as of 2022)
4.3 Date of Key Players Enter into Plasma Fraction Market
4.4 Global Top Players Plasma Fraction Headquarters and Area Served
4.5 Key Players Plasma Fraction Product Solution and Service
4.6 Competitive Status
4.6.1 Plasma Fraction Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Baxter
5.1.1 Baxter Profile
5.1.2 Baxter Main Business
5.1.3 Baxter Plasma Fraction Products, Services and Solutions
5.1.4 Baxter Plasma Fraction Revenue (US$ Million) & (2018-2023)
5.1.5 Baxter Recent Developments
5.2 Octapharma
5.2.1 Octapharma Profile
5.2.2 Octapharma Main Business
5.2.3 Octapharma Plasma Fraction Products, Services and Solutions
5.2.4 Octapharma Plasma Fraction Revenue (US$ Million) & (2018-2023)
5.2.5 Octapharma Recent Developments
5.3 Biotest
5.3.1 Biotest Profile
5.3.2 Biotest Main Business
5.3.3 Biotest Plasma Fraction Products, Services and Solutions
5.3.4 Biotest Plasma Fraction Revenue (US$ Million) & (2018-2023)
5.3.5 CSL Recent Developments
5.4 CSL
5.4.1 CSL Profile
5.4.2 CSL Main Business
5.4.3 CSL Plasma Fraction Products, Services and Solutions
5.4.4 CSL Plasma Fraction Revenue (US$ Million) & (2018-2023)
5.4.5 CSL Recent Developments
5.5 Grifols
5.5.1 Grifols Profile
5.5.2 Grifols Main Business
5.5.3 Grifols Plasma Fraction Products, Services and Solutions
5.5.4 Grifols Plasma Fraction Revenue (US$ Million) & (2018-2023)
5.5.5 Grifols Recent Developments
5.6 Kedrion
5.6.1 Kedrion Profile
5.6.2 Kedrion Main Business
5.6.3 Kedrion Plasma Fraction Products, Services and Solutions
5.6.4 Kedrion Plasma Fraction Revenue (US$ Million) & (2018-2023)
5.6.5 Kedrion Recent Developments
5.7 LFB
5.7.1 LFB Profile
5.7.2 LFB Main Business
5.7.3 LFB Plasma Fraction Products, Services and Solutions
5.7.4 LFB Plasma Fraction Revenue (US$ Million) & (2018-2023)
5.7.5 LFB Recent Developments
5.8 Chinese Biological Products
5.8.1 Chinese Biological Products Profile
5.8.2 Chinese Biological Products Main Business
5.8.3 Chinese Biological Products Plasma Fraction Products, Services and Solutions
5.8.4 Chinese Biological Products Plasma Fraction Revenue (US$ Million) & (2018-2023)
5.8.5 Chinese Biological Products Recent Developments
5.9 Shanghai RAAS Blood Products
5.9.1 Shanghai RAAS Blood Products Profile
5.9.2 Shanghai RAAS Blood Products Main Business
5.9.3 Shanghai RAAS Blood Products Plasma Fraction Products, Services and Solutions
5.9.4 Shanghai RAAS Blood Products Plasma Fraction Revenue (US$ Million) & (2018-2023)
5.9.5 Shanghai RAAS Blood Products Recent Developments
6 North America
6.1 North America Plasma Fraction Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Plasma Fraction Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Plasma Fraction Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Plasma Fraction Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Plasma Fraction Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Plasma Fraction Market Dynamics
11.1 Plasma Fraction Industry Trends
11.2 Plasma Fraction Market Drivers
11.3 Plasma Fraction Market Challenges
11.4 Plasma Fraction Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
